➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
Medtronic
Harvard Business School
AstraZeneca
Dow

Last Updated: March 8, 2021

DrugPatentWatch Database Preview

HERCEPTIN Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for HERCEPTIN

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Seattle Genetics, Inc.Phase 2
Seattle Genetics, Inc.Phase 1/Phase 2
Reva BashoPhase 1/Phase 2

See all HERCEPTIN clinical trials

Recent Litigation for HERCEPTIN

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Genentech, Inc. v. Samsung Bioepis Co. Ltd.2020-06-28
CELGENE CORPORATION v. DR. REDDY'S LABORATORIES, LTD.2019-07-12
Genentech, Inc. v. Pfizer Inc.2019-04-05

See all HERCEPTIN litigation

PTAB Litigation
PetitionerDate
GEMoaB Monoclonals GmbH2019-12-20
2018-04-24
2018-03-20

See all HERCEPTIN litigation

Pharmacology for HERCEPTIN
Mechanism of ActionHER2/Neu/cerbB2 Antagonists

Patent Text Search: US Patents for HERCEPTIN

These patents were identified by searching patent claims

Supplementary Protection Certificates for HERCEPTIN

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
233 5006-2015 Slovakia   Start Trial PRODUCT NAME: IBRUTINIB; REGISTRATION NO/DATE: EU/1/14/945 20141023
93138 Luxembourg   Start Trial PRODUCT NAME: RITUXIMAB ET HYALURONIDASE HUMAINE RECOMBINANTE; FIRST REGISTRATION DATE: 20140326
CR 2015 00021 Denmark   Start Trial PRODUCT NAME: IBRUTINIB ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/14/945 20141023
1490002-1 Sweden   Start Trial MARKETING AUTHORIZATION NUMBER AND DATE OF GRANT/NOTIFICATION: EU/1/13/885, 2013-11-19; PERIOD OF VALIDITY (FROM - UNTIL): 20241013 - 20281118
C300630 Netherlands   Start Trial PRODUCT NAME: TRASTUZUMAB EMTANSINE; REGISTRATION NO/DATE: EU/1/13/885 20131115
122013000157 Germany   Start Trial PRODUCT NAME: TRASTUZUMAB EMTANSINE; REGISTRATION NO/DATE: EU/1/13/885 20131115
PA2015017,C2201840 Lithuania   Start Trial PRODUCT NAME: IBRUTINIBAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA; REGISTRATION NO/DATE: EU/1/14/945 20141021
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Medtronic
Express Scripts
Moodys
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.